All regulatory updates
718 results found
OEHHA lists vinyl acetate as known to cause cancer under Proposition 65 (effective Jan 3, 2025)
OEHHA issued an official notice listing vinyl acetate on the Proposition 65 list as a chemical known to the State of California to cause cancer. Businesses whose products or operations may result in consumer or occupational exposures to vinyl acetate in California should evaluate whether warnings are required and update compliance documentation and supplier inquiries accordingly.
FHWA final rule rescinds Manufactured Products General Waiver and phases in manufactured-products domestic content requirements (final assembly 2025; 55% components 2026)
FHWA published a final rule amending its Buy America regulation for Federal-aid highway projects (23 CFR 635.410) to terminate the longstanding general waiver for manufactured products and establish standards for when manufactured products are considered produced in the United States. The rule provides a phased approach tied to project obligation dates (including a U.S. final assembly requirement starting for projects obligated on/after October 1, 2025, and a 55% domestic component cost requirement for projects obligated on/after October 1, 2026). This change is directly relevant to BABA-aligned domestic preference compliance for highway construction supply chains and contract specifications.
Illinois HB1038 referred to House Rules Committee; bill proposes broader fentanyl penalty increases and reclassification of certain offenses
Illinois HB1038 (104th General Assembly) proposes amendments to the Illinois Controlled Substances Act increasing penalties for fentanyl-related offenses, including increasing sentencing ranges for manufacture/delivery or possession with intent involving specified quantities of substances containing fentanyl (or analogs) and reclassifying certain weight ranges to higher felony classes. The official bill status shows the bill was referred to the House Rules Committee on 2025-01-09. Compliance teams should monitor as it reflects proposed escalation of fentanyl-related criminal exposure that may influence compliance programs and diversion controls if enacted.
HB0077 introduced to schedule xylazine as a Schedule III controlled substance with statutory exemptions
Illinois HB0077 (104th GA) proposes amending the Illinois Controlled Substances Act to schedule xylazine as a Schedule III controlled substance and establish xylazine-specific exemptions (per introduced bill text). Compliance relevance: if enacted, it would add xylazine to Illinois scheduling, changing controlled substance compliance obligations for entities that handle xylazine, with exemptions particularly relevant to veterinary and authorized-use contexts.
HB1038 introduced to increase fentanyl-related penalties (including Class X thresholds and sentencing enhancements)
Illinois HB1038 (104th GA) proposes amendments to the Illinois Controlled Substances Act sections addressing manufacture/delivery and trafficking penalties involving fentanyl (and analogs/mixtures). The bill synopsis and text indicate proposed increases to minimum/maximum sentences for specified fentanyl quantities and changes to felony classifications/penalty add-ons when the substance contains fentanyl. Compliance relevance: if enacted, it would materially change the penalty landscape for fentanyl-related offenses under 720 ILCS 570 and may affect compliance risk evaluations and enforcement sensitivity for entities handling controlled substances.
Illinois HB0338 introduced to make a technical correction to the Act’s short title language (720 ILCS 570/101)
Illinois HB0338 (104th General Assembly) was introduced to amend 720 ILCS 570/101 to make a technical correction to the short title wording of the Illinois Controlled Substances Act. This is a non-substantive/technical drafting fix, but compliance teams tracking statutory citations and legal references may want to monitor it for any downstream impacts on internal legal citations or documentation.
Illinois HB0349 introduced to make a technical correction to the Act’s short title language (720 ILCS 570/101)
Illinois HB0349 (104th General Assembly) was introduced to amend 720 ILCS 570/101 with a similar technical correction to the short title wording of the Illinois Controlled Substances Act. This is not an enacted change and appears technical, but should be monitored for any changes that affect formal statutory referencing.
Illinois HB0077 introduced to schedule xylazine as Schedule III and create statutory exemptions
HB0077 proposes amending the Illinois Controlled Substances Act to add xylazine to Schedule III (amending 720 ILCS 570/208 per research text summary) and to create a new exemption section under which xylazine would not be considered a controlled substance in specified legitimate contexts (notably veterinary/FDA-compliant animal drug uses and certain euthanasia/wildlife biologist uses). Compliance teams should monitor because enactment would introduce controlled-substance controls for xylazine outside exempt channels and require organizations to document exemption eligibility for affected activities.
Illinois HB1038 proposed to increase fentanyl penalties under 720 ILCS 570/401 and 720 ILCS 570/401.1 (stalled in House Rules as of Jan 9, 2025)
HB1038 (104th General Assembly) proposes amendments to 720 ILCS 570/401 and 720 ILCS 570/401.1 to increase fentanyl-related penalties (including reclassification and sentencing changes for certain fentanyl quantities and enhancements when fentanyl is present). The ILGA bill status page shows the most recent action as 2025-01-09 (referred to the House Rules Committee). While not enacted per the provided sources, it remains a relevant proposed change for stakeholders monitoring potential future fentanyl penalty increases under the Illinois Controlled Substances Act.
Illinois HB1038 status update: fentanyl penalty proposal referred to House Rules Committee
The ILGA bill status for HB1038 shows the measure proposing fentanyl penalty changes under the Illinois Controlled Substances Act was referred to the House Rules Committee on 2025-01-09. This reflects legislative status activity (not enactment). Compliance teams tracking potential controlled-substance penalty changes should continue monitoring the bill's progress.
Illinois SB0073 status indicates bill did not advance (Session Sine Die) for prior-session fentanyl penalty proposal
The ILGA bill status page for SB0073 (103rd General Assembly) shows a last action of Session Sine Die on 2025-01-07, indicating the prior-session proposal to amend the Illinois Controlled Substances Act for fentanyl-related penalties did not pass in that session. This is a legislative outcome update relevant for compliance tracking and horizon scanning.
2025 consolidated text of the Stockholm Convention (updated compilation) published
An updated consolidated compilation of the Stockholm Convention text and annexes (2025 version) is available as an official PDF. While this is not itself a new listing decision, it is compliance-relevant as a current reference of the treaty text incorporating adopted amendments up to the compilation date.
ASME BPVC VIII-1 product listing confirms 2025 Edition availability (BPVC.VIII.1–2025)
ASME’s official product listing for BPVC Section VIII, Division 1 shows the edition as BPVC.VIII.1–2025 and notes the standard is under “stabilized maintenance” (with a change-request submission process). This is an authoritative publisher confirmation of the current BPVC VIII-1 edition offering, but it is not a jurisdictional adoption or legally-mandated compliance date. Compliance teams can use this as a reference point for edition control and procurement/availability when preparing for audits or customer/AHJ requirements that specify a particular BPVC edition.
Minnesota: MPCA confirms first Amara’s Law product prohibitions for intentionally added PFAS effective Jan 1, 2025
Minnesota’s Pollution Control Agency compliance page confirms that, starting January 1, 2025, the first product prohibitions under Amara’s Law (Minn. Stat. § 116.943) apply: products in specified categories may not be sold/distributed in Minnesota if they contain intentionally added PFAS. For compliance teams, this is a binding sales/distribution restriction that requires product-content diligence (PFAS intentional addition) and market access controls for Minnesota.
EASA publishes 'Halon replacement in the aviation industry guide 2025' supporting EU halon-free transition (incl. Annex V deadlines and derogations context)
EASA made available the 'Halon replacement in the aviation industry guide 2025' to support implementation of Regulation (EU) 2024/590 in the aviation sector. The guide compiles Annex V deadline information (including the 31 Dec 2025 end date for portable extinguishers protecting cabins and crew compartments) and explains compliance pathways and the derogations process (via Member State competent authority requests to the European Commission). Compliance teams can use this guidance to validate aircraft configuration changes, technical acceptance criteria, and regulatory interaction steps for any exceptional cases.
European Commission RoHS implementation page reiterates exemption renewal validity and transition rules (official procedural guidance)
The European Commission’s RoHS Directive implementation page provides authoritative procedural guidance on exemption renewals under Directive 2011/65/EU. It explains that timely renewal requests keep exemptions valid until a Commission decision is taken, and that rejected renewals typically include a 12–18 month transition period before expiry. It also notes expected decision timelines and links to the exemptions list and exemption application guidance materials. Compliance teams should use this page to plan exemption renewal submissions (18 months before expiry) and manage transition planning when exemptions are rejected or revised.
ASME publishes/maintains BPVC 2025 edition landing page (official edition availability reference)
ASME’s official BPVC 2025 landing page confirms the availability of the 2025 BPVC edition and serves as an official reference point for organizations managing BPVC edition transitions. While not a legal adoption, this page is relevant to ASME BPVC Section VIII Div.1 compliance programs because it signals the current BPVC edition cycle and supports internal document control and procurement planning for the applicable code edition.
Louisiana enacted Act 233 (HB 12, 2025) creating offenses for consumable hemp products and clarifying interaction with UCDSL (industrial hemp exemption)
Louisiana enacted Act 233 (HB 12, 2025), which (per the official résumé digest) creates new offenses related to consumable hemp products (including restrictions involving persons under 21) and makes related changes clarifying how certain hemp products and activities interact with the Uniform Controlled Dangerous Substances Law, including industrial hemp exemption provisions referenced in R.S. 40:961.1 and related controlled substance provisions. The résumé digest states an effective date of August 1, 2025. Compliance teams involved in hemp/consumable hemp products (manufacture, distribution, retail) should reassess Louisiana product legality determinations, age-gating/sales controls, distribution practices, and any policies relying on UCDSL hemp exemptions.
PFAS Regulation in Massachusetts: TURA Reporting and Phased Elimination
Massachusetts manages PFAS through a dual-track system. Under TURA, industrial facilities exceeding specific thresholds must track and report their use of listed PFAS categories. Concurrently, new state legislation has established a phased approach to eliminating intentionally added PFAS from consumer goods and industrial discharges to protect environmental justice populations and municipal water systems. The employee notification deadline is January 1, 2026; TURA reporting and planning are due by July 1, 2026; intentionally added PFAS in specified product categories were subject to elimination as of January 1, 2026; and sales of firefighter turnout gear containing PFAS are prohibited beginning in 2027.
ASME issues BPVC 2025 ordering information listing Section VIII Division 1 (order form PDF)
ASME’s official BPVC 2025 order form PDF lists BPVC publications including Section VIII, Division 1 as part of the 2025 edition offerings (with ordering identifiers such as order numbers/ISBNs). This is not a technical amendment, errata, or jurisdictional adoption notice, but it is compliance-relevant for controlled procurement and ensuring the organization is working to the correct BPVC VIII-1 edition referenced by contracts, Authorized Inspectors, or Authorities Having Jurisdiction.